NTRA insiders

15 insiders have filed at NTRA since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Rabinowitz MatthewExecutive Chairman2.32M1.637%67 sells $119.4M
Healy JamesDirector1.60M1.128%1 sells $37.8M
Botha RoelofDirector1.16M0.817%16 sells $32.5M
Sheena JonathanDirector301.3k0.213%287 sells $42.5M
Rabinowitz DanielSec. And Chief Legal Officer233.3k0.165%58 sells $27.3M
Fesko JohnPresident, Chief Bus. Officer189.2k0.134%41 sells $12.9M
Chapman Steven LeonardCEO And President156.6k0.111%120 sells $146.0M
Moshkevich SolomonPresident, Clinicaldiagnostics150.9k0.107%90 sells $31.7M
Brophy Michael BurkesChief Financial Officer63.4k0.045%111 sells $44.0M
Rosenman HermDirector20.4k0.014%6 sells $17.5M
Baynes Roy D.Director18.4k0.013%14 sells $8.2M
Marcus Gail BoxerDirector5.9k<0.01%33 sells $5.7M
Chapman Rowan EDirector5.8k<0.01%8 sells $2.8M
Williams Brinkley RuthDirector5.4k<0.01%
Bertagnolli MonicaDirector5.3k<0.01%

Full register at boothcheck.com/insiders/NTRA. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

NTRA institutional holders · NTRA research report